Scalpel Weekly News

Week of: February 05, 2018

IN THE NEWS


Nicotine Study Terminated, Animal Studies Result in Monkey Deaths

On January 26, 2018, the FDA Commissioner Scott Gottlieb, M.D., made a statement about the termination of an FDA nicotine study in relation to the FDA’s commitments to humane and judicious animal research. The FDA learned of concerns regarding a study at the FDA’s National Center for Toxicological Research (NCTR). Click title to continue reading...


 
MEDICAL ALERTS


New Treatment for Certain Digestive Tract Cancers

On January 26, 2018, the FDA approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Lutathera is indicated for adult patients with somatostatin receptor-positive GEP-NETs, meaning the tumor cells have receptors for somatostatin—a particular hormone secreted in the pancreas and pituitary gland. Click title to continue reading...



Warnings To Companies Selling Unapproved Opioid Cessation Products

On January 24, 2018, the FDA and the Federal Trade Commission (FTC) posted joint warning letters to the marketers and distributors of 12 opioid cessation products for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal. Click title to continue reading...



More Birth Defects Seen in Parts of U.S. with Local Zika Spread

On January 25, 2018, the CDC published a report that found an increase in birth defects most strongly linked to Zika virus infection during pregnancy in parts of the United States that have had local Zika virus transmission. Areas with local transmission of Zika, specifically, southern Florida, a portion of south Texas, and Puerto Rico, saw a 21 percent increase in births with outcomes most strongly linked to Zika virus in the last half of 2016 compared with births in the first half of that year. Click title to continue reading...


  CASE ALERTS


Sudden Cardiac Death; Discovery Sanctions after Dismissal

A 37-year-old man was under the care of a family practitioner. The family practitioner prescribed the man medication for the treatment of hypertension. The man suffered a cardiac arrest and died suddenly. Click title to continue reading...



Failure to Prevent Rh-Sensitization during Pregnancy; Discovery Rule

During her first pregnancy, a woman sought the care of a doctor. Testing revealed that the woman’s blood type was Rh-negative. Testing revealed that the baby’s blood type was Rh-positive, creating a risk for Rh-sensitization if their blood mixed. Click title to continue reading...



Failure to Diagnose Ileus after Hernia Repair Surgery

A surgeon performed laparoscopic surgery on a man to repair a ventral hernia, a bulge of tissues through an opening of weakness within the abdominal wall muscles. The man attended two follow-up visits with the surgeon. Click title to continue reading...


FEATURE


Interrogatories to Defendant: Unnecessary Cardiac Procedure

As a special feature for our Premium subscribers we have included this feature containing illustrative interrogatories to be used as a guide for counsel preparing interrogatories to the defendant physician in an action involving an unnecessary cardiac procedure. In this illustrative situation, a man received a cardiac catheterization and stent placement procedure. Click title to continue reading...